Currently, available treatments, like tissue plasminogen activator (tPA) [8, 9] and thrombectomy, can only be given during a narrow time window within the first few hours after stroke onset, and are therefore available only to a small number of patients [8, 10]. This evidence concerns the gene PLAT and stroke disorder.